This test detects the V617F mutation for JAK2. This assay aids in the distinction between Reactive cytosis & Chronic myeloproliferative disorder.






*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals
*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals
*The Diagnostic Monitoring Tests will be done once the Free Trial Period is over
*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals
*The Diagnostic Monitoring Tests will be done once the Free Trial Period is over
*Our customer care team will reach out to you for scheduling the sample collection at the defined intervals